Literature DB >> 24836863

Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A.

Nuria García Segarra1, Ivan Gautschi2, Laureane Mittaz-Crettol3, Christine Kallay Zetchi4, Lama Al-Qusairi2, Miguel Xavier Van Bemmelen2, Philippe Maeder5, Luisa Bonafé3, Laurent Schild2, Eliane Roulet-Perez4.   

Abstract

Mutations in the CACNA1A gene, encoding the α1 subunit of the voltage-gated calcium channel Ca(V)2.1 (P/Q-type), have been associated with three neurological phenotypes: familial and sporadic hemiplegic migraine type 1 (FHM1, SHM1), episodic ataxia type 2 (EA2), and spinocerebellar ataxia type 6 (SCA6). We report a child with congenital ataxia, abnormal eye movements and developmental delay who presented severe attacks of hemiplegic migraine triggered by minor head traumas and associated with hemispheric swelling and seizures. Progressive cerebellar atrophy was also observed. Remission of the attacks was obtained with acetazolamide. A de novo 3 bp deletion was found in heterozygosity causing loss of a phenylalanine residue at position 1502, in one of the critical transmembrane domains of the protein contributing to the inner part of the pore. We characterized the electrophysiology of this mutant in a Xenopus oocyte in vitro system and showed that it causes gain of function of the channel. The mutant Ca(V)2.1 activates at lower voltage threshold than the wild type. These findings provide further evidence of this molecular mechanism as causative of FHM1 and expand the phenotypic spectrum of CACNA1A mutations with a child exhibiting severe SHM1 and non-episodic ataxia of congenital onset.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetazolamide response; Congenital ataxia; Developmental delay; Gain of function; Novel CACNA1A mutation; Severe SHM1

Mesh:

Substances:

Year:  2014        PMID: 24836863     DOI: 10.1016/j.jns.2014.04.027

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

Review 1.  The expanding spectrum of neurological phenotypes in children with ATP1A3 mutations, Alternating Hemiplegia of Childhood, Rapid-onset Dystonia-Parkinsonism, CAPOS and beyond.

Authors:  Matthew T Sweney; Tara M Newcomb; Kathryn J Swoboda
Journal:  Pediatr Neurol       Date:  2014-10-13       Impact factor: 3.372

2.  The complexities of CACNA1A in clinical neurogenetics.

Authors:  Marina P Hommersom; Teije H van Prooije; Maartje Pennings; Meyke I Schouten; Hans van Bokhoven; Erik-Jan Kamsteeg; Bart P C van de Warrenburg
Journal:  J Neurol       Date:  2021-11-22       Impact factor: 6.682

Review 3.  The electrophysiological footprint of CACNA1A disorders.

Authors:  Elisabetta Indelicato; Iris Unterberger; Wolfgang Nachbauer; Andreas Eigentler; Matthias Amprosi; Fiona Zeiner; Edda Haberlandt; Manuela Kaml; Elke Gizewski; Sylvia Boesch
Journal:  J Neurol       Date:  2021-02-05       Impact factor: 4.849

4.  Biallelic variants in genes previously associated with dominant inheritance: CACNA1A, RET and SLC20A2.

Authors:  A Arteche-López; M I Álvarez-Mora; M T Sánchez Calvin; J M Lezana Rosales; C Palma Milla; M J Gómez Rodríguez; I Gomez Manjón; A Blázquez; A Juarez Rufián; P Ramos Gómez; O Sierra Tomillo; I Hidalgo Mayoral; R Pérez de la Fuente; I J Posada Rodríguez; L I González Granado; Miguel A Martin; J F Quesada-Espinosa; M Moreno-García
Journal:  Eur J Hum Genet       Date:  2021-07-15       Impact factor: 5.351

5.  Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients.

Authors:  Chih-Yang Wang; Ming-Derg Lai; Nam Nhut Phan; Zhengda Sun; Yen-Chang Lin
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

6.  A Single Amino Acid Deletion (ΔF1502) in the S6 Segment of CaV2.1 Domain III Associated with Congenital Ataxia Increases Channel Activity and Promotes Ca2+ Influx.

Authors:  Maria Isabel Bahamonde; Selma Angèlica Serra; Oliver Drechsel; Rubayte Rahman; Anna Marcé-Grau; Marta Prieto; Stephan Ossowski; Alfons Macaya; José M Fernández-Fernández
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

7.  Clinically severe CACNA1A alleles affect synaptic function and neurodegeneration differentially.

Authors:  Xi Luo; Jill A Rosenfeld; Shinya Yamamoto; Tamar Harel; Zhongyuan Zuo; Melissa Hall; Klaas J Wierenga; Matthew T Pastore; Dennis Bartholomew; Mauricio R Delgado; Joshua Rotenberg; Richard Alan Lewis; Lisa Emrick; Carlos A Bacino; Mohammad K Eldomery; Zeynep Coban Akdemir; Fan Xia; Yaping Yang; Seema R Lalani; Timothy Lotze; James R Lupski; Brendan Lee; Hugo J Bellen; Michael F Wangler
Journal:  PLoS Genet       Date:  2017-07-24       Impact factor: 5.917

8.  Genomic analysis identifies masqueraders of full-term cerebral palsy.

Authors:  Yusuke Takezawa; Atsuo Kikuchi; Kazuhiro Haginoya; Tetsuya Niihori; Yurika Numata-Uematsu; Takehiko Inui; Saeko Yamamura-Suzuki; Takuya Miyabayashi; Mai Anzai; Sato Suzuki-Muromoto; Yukimune Okubo; Wakaba Endo; Noriko Togashi; Yasuko Kobayashi; Akira Onuma; Ryo Funayama; Matsuyuki Shirota; Keiko Nakayama; Yoko Aoki; Shigeo Kure
Journal:  Ann Clin Transl Neurol       Date:  2018-03-26       Impact factor: 4.511

9.  Genetic Evidence for Possible Involvement of the Calcium Channel Gene CACNA1A in Autism Pathogenesis in Chinese Han Population.

Authors:  Jun Li; Yang You; Weihua Yue; Meixiang Jia; Hao Yu; Tianlan Lu; Zhiliu Wu; Yanyan Ruan; Lifang Wang; Dai Zhang
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

10.  Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG): Evidence for Hypoglycosylation-Driven Channelopathy.

Authors:  Mercè Izquierdo-Serra; Antonio F Martínez-Monseny; Laura López; Julia Carrillo-García; Albert Edo; Juan Darío Ortigoza-Escobar; Óscar García; Ramón Cancho-Candela; M Llanos Carrasco-Marina; Luis G Gutiérrez-Solana; Daniel Cuadras; Jordi Muchart; Raquel Montero; Rafael Artuch; Celia Pérez-Cerdá; Belén Pérez; Belén Pérez-Dueñas; Alfons Macaya; José M Fernández-Fernández; Mercedes Serrano
Journal:  Int J Mol Sci       Date:  2018-02-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.